Connect with us

Hi, what are you looking for?

Mucosal Atomization Devices Market Is Set To Expand At A CAGR Of 7.12% To Reach S$ 1,045.20 Million By The Year 2027 – IMARC Group

According to the latest report by IMARC Group, titled “Global Mucosal Atomization Devices Market Report, Size, Share, Industry Trends, Growth, Opportunity and Forecast 2022-2027“, the global mucosal atomization devices market reached a value of US$ 676.5 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1,045.20 Million by 2027, exhibiting a CAGR of 7.12% during 2022-2027.

Mucosal atomization devices are drug delivering devices that administer atomized drugs to treat chronic diseases such as allergic rhinitis and sinusitis. These non-invasive devices deliver drugs through the nasal mucosa or nostrils. They consist of syringes and a small-sized atomizing tip at the end of a flexible applicator, partially covered by foam, which turns the medicine into a fine mist. These devices offer superior efficiency and allow rapid absorption of the therapeutics. They are also gaining popularity as an efficient alternative to the traditional needle-based injection drug delivery method as they are safe to use, systematic, painless, and flexible. Consequently, they are used across hospitals, specialized clinics, and ambulatory surgical centers.


Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/mucosal-atomization-devices-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.


Mucosal Atomization Devices Market Trends and Drivers:

The global mucosal atomization devices market is primarily driven by the increasing demand for non-invasive and effective drug delivery systems that offer quicker recovery and less painful options. 

Besides this, there has been widespread adoption of mucosal atomization devices as they help in the faster delivery of medication in the bloodstream and reduce the time of the medicine to act on the concerned medical issue. Nowadays, mucosal atomization devices are commonly available in gas-propelled variants containing highly pressurized nitrogen gas and offering convenient access to large mucosal surfaces, which is favoring the market growth. 

In addition, manufacturers are launching auto-disposable variants that are safe and hygienic. Furthermore, the significant growth of the healthcare industry and the implementation of various government initiatives to promote public health is anticipated to facilitate market growth in the upcoming years.


Global Mucosal Atomization Devices Market 2022-2027 Analysis and Segmentation:


Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare), Kurve Technology Inc., Life-Assist Inc., Medica Holdings LLC, MedTree (BTME Group Ltd.) and Teleflex Incorporated. 


Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/mucosal-atomization-devices-market

The report has segmented the market on the basis of region, product type, technology and end user.


Breakup by Product Type:

Nasal Atomization Devices

Fiber-Optic Atomization Devices

Laryngo-Tracheal Atomization Devices

Bottle Atomizer Devices


Breakup by Technology:

Gas Propelled

Electrical


Breakup by End User:

Hospitals

Clinics

Ambulatory Surgical Centers

Others


Breakup by Region:

North America: (United States, Canada)

Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)

Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)

Latin America: (Brazil, Mexico, Others)

Middle East and Africa


Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5370&flag=F

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.


Key highlights of the report:

Market Performance (2016-2021)

Market Outlook (2022- 2027)

Porter’s Five Forces Analysis

Market Drivers and Success Factors

SWOT Analysis

Value Chain

Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Services Private Limited.

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

 

Written By

You may also like:

Tech & Science

The CDC revealed Friday it is now tracking a new COVID-19 variant of concern around the U.S. known as XBB.

Business

We saw North Korean nation-state threat actors exploiting Log4shell to hack energy providers and conduct espionage campaigns.

Tech & Science

AI can replace you guys, too. All it needs is a script, you know.

Tech & Science

Avian flu wiped out 50.54 million birds in the United States this year, making it the country’s deadliest outbreak in history.